CAMBRIDGE, Mass. (AP) _ Momenta Pharmaceuticals Inc. (MNTA) on Monday reported a loss of $57 million in its second quarter.

On a per-share basis, the Cambridge, Massachusetts-based company said it had a loss of 48 cents.

The results missed Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for a loss of 42 cents per share.

The biotechnology company posted revenue of $6.6 million in the period, beating Street forecasts. Five analysts surveyed by Zacks expected $5.8 million.

Momenta shares have increased 67% since the beginning of the year. The stock has nearly tripled in the last 12 months.

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on MNTA at https://www.zacks.com/ap/MNTA

Automated Insights, source Associated Press News